Taubman Scholar John M. Carethers, MD, takes helm of physicians’ group

John M. Carethers, MD, MACP, has begun his term as president of the Association of American Physicians (AAP).  The association is a nonprofit, professional organization founded in 1885 for “the advancement of scientific and practical medicine.” The association is composed of members who are leading senior physician scientists and are competitively selected. Dr. Carethers is…

Lab study may power new treatment to correct crossed eyes

By learning how zebrafish regenerate their eye muscles, researchers could help figure out how to help humans do the same. University of Michigan Kellogg Eye Center (link is external) researchers have published findings in PLOS One (link is external) on the role of insulin-like growth factor (IGF) in promoting extraocular muscle repair and regeneration in zebrafish. If the process…

Emerging Scholar tapped for featured lecture

Johann Gudjonsson, MD, PhD, has been selected to deliver the “Rising Star” lecture at the International Investigative Dermatology conference in May. Rising Star lectures celebrate the best of emerging dermatological science throughout the world; prominent young researchers engaged in high-impact science are invited to provide a short overview on their current work.   Dr. Gudjonsson is the…

Michelle Kahlenberg, MD, PhD selected for a prestigious lectureship by the Rheumatology Research Foundation

Taubman Institute Emerging Scholar Michelle Kahlenberg, MD, PhD, recently was selected for a prestigious lectureship by the Rheumatology Research Foundation. Dr. Kahlenberg is a rheumatologist and assistant professor of internal medicine at U-M. In addition to caring for patients, she runs a research laboratory that specializes in the study of systemic lupus erythematosus, an autoimmune…

2017 Taubman Prize awarded to Stephen Hauser, MD

2017 Taubman Prize winner’s research led to new drug treatment for MS

Ann Arbor, Mich —  A physician-researcher whose work challenged conventional thinking about multiple sclerosis (MS) is the 2017 recipient of the $100,000 Taubman Prize for Excellence in Translational Medical Research, the A. Alfred Taubman Medical Research Institute announced.

Stephen L. Hauser, M.D., director of the UCSF Weill Institute for Neurosciences and professor and chair of the Department of Neurology at the University of California, San Francisco, will receive the honor in recognition of his paradigm-changing discoveries that paved the way for a highly effective drug in the treatment of MS.

Hauser will accept the award and deliver a keynote talk at the Taubman Institute’s annual symposium on October 20 in Ann Arbor.